CIK 0001662579 · Non-accelerated filer<br>Smaller reporting company
C4 Therapeutics, Inc.
Sign in to watch- Ticker
- CCCC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475617627
- Phone
- (617) 231-0700
- Business address
- 490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-10-01 | COHEN MARC A Director | Grant or award · Stock Option (Right to Buy) | +17,786 | 17,786 | ||
| 2020-10-01 | Prokupets Elena Director | Grant or award · Stock Option (Right to Buy) | +17,786 | 17,786 | ||
| 2020-10-01 | DOWNEY BRUCE Director | Grant or award · Stock Option (Right to Buy) | +17,786 | 17,786 | ||
| 2020-10-01 | COHEN ALAIN J Director | Grant or award · Stock Option (Right to Buy) | +17,786 | 17,786 | ||
| 2020-10-01 | Anderson Kenneth Carl Director | Grant or award · Stock Option (Right to Buy) | +17,786 | 17,786 |
Page 27 of 27 · 525 trades